1Braunwald, E. Mechanism of action of calcium-channel-blocking agents. N Engl J Med 1982; 307: 1618–27.
2Hollister, LE, Trevino, ES. Calcium channel blockers in psychiatric disorders: a review of the literature. Can J Psychiatry 1999; 44: 658–64.
3Cipriani, A, Saunders, K, Attenburrow, MJ, Stefaniak, J, Panchal, P, Stockton, S, et al. A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development. Mol Psychiatry 2016; 21: 1324–32.
4Nanou, E, Catterall, WA. Calcium channels, synaptic plasticity, and neuropsychiatric disease. Neuron 2018; 98: 466–81.
5Dolphin, AC. Calcium channel auxiliary alpha(2)delta and beta subunits: trafficking and one step beyond. Nat Rev Neurosci 2012; 13: 542–555.
6Zamponi, GW, Striessnig, J, Koschak, A, Dolphin, AC. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol Rev 2015; 67: 821–70.
7Heyes, S, Pratt, WS, Rees, E, Dahimene, S, Ferron, L, Owen, MJ, et al. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog Neurobiol 2015; 134: 36–54.
8Harrison, PJ. Recent genetic findings in schizophrenia and their therapeutic relevance. J Psychopharmacol 2015; 29: 85–96.
9Breen, G, Li, Q, Roth, BL, O'Donnell, P, Didriksen, M, Dolmetsch, R, et al. Translating genome-wide association findings into new therapeutics for psychiatry. Nat Neurosci 2016; 19: 1392–6.
10Ostacher, MJ, Iosifescu, DV, Hay, A, Blumenthal, SR, Sklar, P, Perlis, RH. Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association. Bipolar Disord 2014; 16: 199–203.
11Kabir, ZD, Lee, AS, Rajadhyaksha, AM. L-type Ca(2+) channels in mood, cognition and addiction: integrating human and rodent studies with a focus on behavioural endophenotypes. J Physiol 2016; 594: 5823–37.
12Dedic, N, Pohlmann, ML, Richter, JS, Metha, D, Czamara, D, Metzger, MW, et al. Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood. Mol Psychiatry 2018; 23: 533–543.
13Moon, AL, Haan, N, Wilkinson, LS, Thomas, KL, Hall, J. CACNA1C: Association with psychiatric disorders, behavior, and neurogenesis. Schizophr Bull 2018; 44: 958–65.
14Degoulet, M, Stelly, CE, Ahn, K-C, Morikawa, H. L-type Ca2+ channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory. Mol Psychiatry 2016; 21: 394–402.
15Ou, X, Crane, DE, MacIntosh, BJ, Young, LT, Arnold, P, Ameis, S, et al. CACNA1C rs1006737 genotype and bipolar disorder: Focus on intermediate phenotypes and cardiovascular comorbidity. Neurosci Biobehav Rev 2015; 55: 198–210.
16Atkinson, LZ, Colbourne, L, Smith, A, Harmer, CH, Nobre, AC, Rendell, J, et al. The Oxford study of calcium channel antagonism, cognition, mood instability and sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study. Trials 2019; 20: 120.
17Hayes, JF, Lundin, A, Wicks, S, Lewis, G, Wong, ICK, Osborn, DPJ, et al. Association of hydroxylmethyl glutaryl coenzyme A reductase inhibitors, L-Type calcium channel antagonists, and biguanides with rates of psychiatric hospitalization and self-harm in individuals with serious mental illness. JAMA Psychiatry 2019; 76: 382–90.
18Liss, B, Striessnig, J. The Potential of L-Type calcium channels as a drug target for neuroprotective therapy in Parkinson's disease. Annu Rev Pharmacol Toxicol 2019; 59: 263–89.
19Boal, AH, Smith, DJ, McCallum, L, Muir, S, Touyz, RM, Dominiczak, AF, et al. Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders. Hypertension 2016; 68: 1132–1138.
20Siddiqi, FH, Menzies, FM, Lopez, A, Stamatakou, E, Karabiyik, C, Ureshino, R et al. Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing. Nat Commun 2019; 10: 1817.
21Clark, M, Wrzesinski, T, Garcia-Bea, A, Kleinman, J, Hyde, T, Weinberger, DR, et al. Long-read sequencing reveals the splicing profile of the calcium channel gene CACNA1C in human brain. bioRxiv 2018: 260562.